Chapman University

Chapman University Digital Commons
Psychology Faculty Articles and Research

Psychology

7-2018

Cold Pressor Pain Response in Children with Cancer
Brooke N. Jenkins
Ryan J. Roemer
Ariana Martinez
Tara K. Torres
Michelle A. Fortier

Follow this and additional works at: https://digitalcommons.chapman.edu/psychology_articles
Part of the Oncology Commons, and the Pediatrics Commons

Cold Pressor Pain Response in Children with Cancer
Comments
This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Journal of
Pediatric Hematology/Oncology, volume 40, issue 5, in 2018 following peer review. The definitive
publisher-authenticated version is available online at https://doi.org/10.1097/MPH.0000000000001219.

Copyright
Wolters Kluwer Health, Inc.

1

Cold Pressor Pain Response in Children with Cancer

Brooke N. Jenkins,1,2 PhD; Ryan J. Roemer,2,3 PsyD; Ariana Martinez,2,4 BS; Tara K. Torres,2,4,5
BA; & Michelle A. Fortier,2,4 PhD
1

Department of Psychology, Chapman University

2

UCI Center on Stress and Health, School of Medicine, University of California-Irvine
3

Department of Pediatric Psychology, CHOC Children’s Hospital, Orange, CA

4

Department of Anesthesiology & Perioperative Care, University of California-Irvine
5

Department of Psychology and Social Behavior, University of California-Irvine

Author Note
No conflict of interest by any author. This study was funded in part by the UC Cancer
Research Coordinating Committee (UCCRCC-53097).
Disclosures: The authors have no conflicts of interest or funding to disclose.

All correspondence concerning this article should be addressed to Michelle A. Fortier,
PhD, CHOC Children’s Hospital, 505 S. Main St., Suite 940, Orange, CA 92868, USA, E-mail:
mfortier@uci.edu.

2
Abstract
Objective: The goal of this study was to examine pain responses in pediatric patients with cancer.
Method: Children (ages 6 to 18) undergoing treatment for cancer (N = 68) completed the cold
pressor task.
Results: Average pain tolerance was 118.22 seconds (SD = 101.18) and 40% of the children kept
their hand in the water the entire 4-minute ceiling. On a 0 to 10 numeric rating scale, children
reported a pain severity of 5.07 (SD = 3.47) at their first report of pain, a pain severity of 5.94 (SD
= 3.54) at their max report of pain, and a pain severity of 5.33 (SD = 3.72) at the time they reached
pain tolerance. Children receiving chemotherapy agents (N = 56) with possible neuropathic effects
exhibited higher pain tolerance compared to children not receiving such treatments (N = 10), β =
0.84, SE = 0.38, Wald X21 = 4.88, p = 0.027, hazard ratio = 2.33, 95% confidence interval (1.104.92).
Conclusion: This study provides data on experimental pain responses in a sample of children
undergoing cancer treatment and suggests that pain experience may be moderated by cancer
treatment type.
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Introduction
Pain is a complex and multifaceted phenomenon, which can be difficult to assess
objectively. Safe and effective methods of experimental pain induction have been used to
provide knowledge of pain mechanisms, experience, and responses in controlled settings.1
Research involving experimental pain in children has fostered several interventions which
minimize pain and improve the management of its negative sequelae in clinical settings.2
The cold pressor task (CPT) is one of the most commonly used methods of inducing
experimental pain in pediatric populations due to its ethical acceptability and degree of
experimental control.3,4 The CPT gradually induces ischemic pain through placing a hand or
forearm in cold water.5 The development and adherence to standardization guidelines for CPT
methodology allows for comparison of pain characteristics across populations.4 Normative data
on pain outcomes for children facilitate standardization of the CPT and may be useful in
evaluating the influence of demographic, psychological, and illness-specific variables. For
example, Trapanotto et al5 reported that using a 3-minute uninformed ceiling (ie, children did not
know they would be asked to remove their hand after 3 minutes) and 10° Celsius water, 50% of
healthy children between the ages of 8 and 12 years old reached pain tolerance (i.e., removed
their hand from the water) within 66 seconds and 35% of children kept their hands in the water
the entire three minutes. Furthermore, consistent with previous research, older children exhibited
greater pain tolerance. Previous literature has also shown sex differences in responses to the CPT
with male children demonstrating greater pain tolerance.6 Normative data such as this but
focused on clinical populations may be useful in evaluating how psychological variables such as
anxiety and illness-specific variables such as treatment influence pain outcomes. For example,
anxiety has been associated with increases in pain perception among healthy children.7 It is
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necessary to understand this association between anxiety and pain in clinical populations as well
in order to develop tailored interventions.
Although the majority of extant literature on experimental pain has focused on healthy
children, the CPT has also been used to study clinical samples of children with chronic illness or
recurrent pain, including juvenile rheumatoid arthritis,8,9 recurrent abdominal pain,10 sickle cell
disease,11 and headaches12 for a review see Birnie et al2). Findings in terms of pain behavior
differences between clinical and nonclinical pediatric samples have been mixed. For example, 2
studies showed that children with juvenile idiopathic arthritis exhibited lower pain tolerance than
controls in response to the CPT.8,9 In contrast, children with recurrent abdominal pain responded
with similar pain tolerance and intensity ratings as healthy controls.10 Likewise, children with
recurrent headaches reported no differences in pain intensity ratings compared to healthy
children.13 In a study comparing healthy children with a pediatric chronic pain population, no
significant overall differences were observed in pain tolerance and pain intensity when an
uninformed ceiling was used; however, significant differences emerged in tolerance with a
greater percentage of children with chronic pain completing the CPT when an informed, 1
minute ceiling was used (ie, children were aware they would be asked to remove their hand after
1 minute12).
Despite the wide body of literature involving the CPT in children, we found no studies
involving pediatric samples with cancer, a population who is subject to repeated painful
procedures or medical interventions. Evidence suggests that repeated exposure to painful and
distressing medical procedures may contribute to the development of chronic pain and impact
expectations and reactions to health care interventions and other future painful events.14,15 It is
therefore likely that children with cancer who must undergo repeated medical procedures may
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have unique responses to experimental pain tasks, such as the CPT. Studying this population may
provide valuable information in understanding the developing pain experience of children as well
as inform interventions for the management of recurrent pain.3 A better understanding of how
children with cancer respond to pain could improve clinical practice. For example, altered pain
response as a function of exposure to repeated painful procedures or treatment may place
children at risk for future chronic pain.16,17
The pain resulting from diagnostic and treatment procedures in children with cancer does
not decrease with repeated exposure and may worsen in the absence of adequate pain
management.18 In addition to frequent painful procedures, children being treated for cancer often
also suffer from disease-specific pain and side effects of treatment protocols, including
mucositis, infection, and chemotherapy-induced peripheral neuropathy (CIPN).19,20 CIPN is an
increasingly common neuropathic pain syndrome believed to be caused by neurotoxicity of
chemotherapeutic agents that damage the primary sensory neurons.21 Painful CIPN symptoms
include hyperesthesia; increased physical sensitivity, especially of the skin; allodynia; experience
of pain from a nonpainful stimulation such as pressure, heat or cold; and paresthesias, which are
abnormal sensations such as tingling or prickling “pins and needles.”19 In addition, CIPN is also
known to cause decreased reflexes and a loss of feeling or sensitivity to temperature and tactile
stimuli, which may decrease patients’ perception and response to various external stimuli
including pain (for review see Gilchrist20). Thus, there are many factors that may impact the pain
experience of children undergoing treatment for cancer. Using the CPT in this population
provides a standardized environment to test interventions aimed at reducing pain in children with
cancer. The pain children experience during medical procedures can vary dramatically (based on,
eg, procedure type, previous experience, or physician skill) and so comparing pain reduction
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strategies using a controlled pain induction technique allows researchers to better assess the
direct effects of such pain strategies while controlling for environmental differences. The goal of
this paper is to contribute to our body of knowledge on pain experiences of children being treated
for cancer in order to improve pain management in this vulnerable population.
Given the dearth of experimental pain research on children with cancer and the
importance of understanding factors that impact pain in this population, the purpose of the
present study was to investigate pain responses of children undergoing treatment for cancer using
the CPT with the following specific aims: (1) descriptively assess pain tolerance and severity as
well as explore the correlation between them in children with cancer and (2) examine how
demographic, psychological, and treatment-related variables play a role in pain tolerance and
severity. On the basis of previous research,5,6 specific hypotheses included: (1) greater pain
tolerance would be associated with lower pain severity; (2) older children, children who were
less anxious, and male children would have a greater pain tolerance and experience less pain
severity; and (3) children with treatments that likely lead to CIPN would have higher levels of
pain tolerance and lower levels of pain severity.
Materials and Methods
Participants
Participants included 68 pediatric patients diagnosed with cancer (38.4% female), with a
mean age of 11.67 years (SD = 3.79; range = 6 to18). Participants were part of a larger study
examining the impact of emotion regulation on pain response in children with cancer.
Participants were currently undergoing outpatient treatment for cancer at the Hyundai Cancer
Institute at the Children’s Hospital of Orange County (CHOC Children’s) in Southern California.
Most (57%) children were undergoing treatment for leukemias, 14% were diagnosed with central
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nervous system tumors, 14% had sarcomas, 7% had lymphomas, and 8% had another type of
cancer such as germ-cell tumors, Wilms’ tumor, and breast cancer. Most (94.5%) children
reported English and 5.5% reported Spanish as their primary language. Patients excluded from
the study were those who (1) had a cognitive impairment, such as a developmental delay that
would prevent participation in the CPT, (2) had a medical status requiring inpatient
hospitalization or otherwise signified health complications that would prevent participation, (3)
had a cut or sore on their non-dominant hand, or (4) had a history of upper extremity vascular
disease, high blood pressure, cardiovascular disorder, fainting, seizures, frostbite, or chronic
noncancer pain (defined as pain lasting for > 4 months).
Measures
Demographic information. Demographic variables including child age, ethnicity,
primary language, and sex were collected using self-report measures completed by the child’s
parent.
Medical Record abstraction. Medical records were abstracted from the CHOC
Children’s Hospital Hyundai Cancer Institute to assess specific diagnosis and treatment.
Treatment type was then coded to reflect whether or not a child was receiving a treatment with a
chemotherapy agent known to cause CIPN (CIPN-associated treatment vs. no CIPN-associated
treatment).
Pain tolerance. Pain tolerance was defined as the amount of time a child kept their hand
in the cold water.4 Increased time indicated higher pain tolerance (i.e., that the child could endure
more pain).
Numeric Rating Scale (NRS). Children were asked to report their pain and upset at 30
second intervals throughout the CPT, beginning at the first 30 second mark, using numeric rating
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scales with developmentally appropriate anchors.22-24 Specifically, children were asked “How
much pain are you in (is it hurting) right now?” on a scale of “no pain at all” = 0 to “a lot of
pain” = 10. In addition, children were asked “How upset are you right now?” on a scale of “not
upset” = 0 to “very upset” = 10. Children also completed the ratings upon removing their hand
from the water. First reported pain and upset, worst reported pain and upset (ie, highest value),
and reported pain and upset at pain tolerance (ie, time of hand removal) were used as the
variables of interest in analyses.
The Childhood Anxiety Sensitivity Index (CASI). The CASI25 is an 18-item self-report
scale that measures the tendency to view anxiety-related bodily sensations as dangerous (eg, “It
scares me when my heart beats fast”). Items are scored on a 3-point scale (none, some, a lot), and
total scores are calculated by summing all items. The CASI has demonstrated high internal
consistency (α = 0.87) and adequate test-retest reliability (Cronbach’s α range = 0.62 to 0.78 over
2 wk25) and has been validated with children ages 6 to 18 years old.26-28 The reliability of the
CASI in this study was high (Cronbach’s α = 0.82).
Procedures
Participants for this study were identified through review of appointment schedules, the
participants’ medical records, and consultation with the nursing team. Participants were
approached on the day of their medical appointment and were asked if they would like to
participate. Participants were told that the purpose of the study was to measure their stress
response to a difficult task, identified as “The Cold Water Game,” in which they would place
their hand in cold water for a few minutes and rate how much or little it hurts and how they feel.
Families were informed that no lasting risks were involved and they could withdraw from the
study at any point without penalty. Informed consent and assent were obtained as appropriate.
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Following consent to participate, participants were scheduled for a study appointment on a day
when they were not receiving an infusion, if possible. All procedures were approved by the
Institutional Review Board and followed the American Psychological Association Ethical
Principles with regard to sample treatment.
On the day of the experiment, participants and their parents were directed to complete
demographic information jointly. The child was then separated from their parent to control for
parental influence on behavior, and taken to the CPT laboratory room to complete baseline
questionnaires and the CPT. The child was instructed “we are going to ask you to place your
hand in cold water for a few minutes, but you can remove your hand if it becomes unbearable.
While your hand is in the water you will be asked to rate how much or how little it hurts, and
how good or how bad you feel at various time points. During the experiment, we will also ask
you several questions about your feelings and behavior.” As part of the larger study, children
were also instructed to engage in one of three emotion regulation strategies (distraction,
reappraisal, or empathy) described below.
Emotion regulation strategies. Children were randomly assigned to one of three
emotion regulation strategies. In the distraction condition, children viewed a documentary of
animals and were told to focus on the video. In the reappraisal condition, children were asked to
think about how their participation would help kids like them with cancer. In the empathy
condition, the research assistant told the children “Look, I’m really sorry that you have to do this.
I know how it feels. The cold can be painful, but don’t be nervous. I’ve been through this and it’s
alright, you’re going to be okay.” No group differences in pain emerged between the groups
(presented in the results section) and therefore groups were combined for all other analyses.
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Cold pressor task. The CPT consisted of 2 phases, following guidelines suggested by
von Baeyer et al.4 An experimenter was present throughout the session and stood behind the
child during the CPT.
The initial phase, lasting 2 minutes, was conducted with room temperature water in a
separate tub to allow the child to become familiarized with the laboratory environment,
standardize hand temperature for the CPT, and ensure comprehension of experimental
procedures. The child’s hand was placed in the water up to the wrist. Every 30 seconds, the
experimenter asked the child to provide pain and upset ratings. After the 2-minute baseline, the
child was prompted to remove their hand from the tub and provided with a towel to dry their
hand.
The child was then informed they would participate in the second phase, the CPT. In the
task, the child would place their hand in the cold pressor apparatus, which consisted of a
Coleman cooler that was kept cold with a commercial chiller. The cooler had a thermostat and a
water pump circulating the water to maintain a temperature of 7° C. Participants were instructed
to submerse their non-dominant hand into the cold water up to their wrist. During this phase,
pain and upset ratings were elicited every 30 seconds, up to 8 times during the task, and at the
time of hand removal. The experimenter recorded the time of hand removal and the child was
directed to complete post-task questionnaires. A 4-minute uninformed ceiling was used such that
participants were asked to remove their hand from the water if after 4 minutes they had not
already done so. The duration of experienced pain was under the control of the child as they
could remove their hand from water at any time, with pain rapidly dissipating subsequent to hand
withdrawal.
Statistical Analysis
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First, emotion regulation differences in pain tolerance and self-reported pain and upset
were tested. A Cox hazard regression was used to examine emotion regulation condition
differences in pain tolerance. Cox hazard regression does not assume a normal distribution for
the dependent variable (in this case time until hand removal). Furthermore, because some
children did not remove their hand until they were instructed to do so, we right-censored their
data as it is unknown when they would have taken their hand out had they not been instructed to
do so. Analysis of variance was used to examine emotion regulation condition differences in pain
and upset at the three time points of interest (first reported pain and upset, worst reported pain
and upset, and reported pain and upset at pain tolerance).
Second, means, SDs, medians, and interquartile ranges were used to calculate averages
for pain tolerance and self-reported pain and upset ratings. Pearson product-moment correlations
were used to examine relationships between pain, upset, and pain tolerance. Third, pearson
product-moment correlations were used to examine how age, sex, and anxiety sensitivity were
associated with pain tolerance and self-reported pain and upset. Fourth, a Cox hazard regression
model was used to examine group differences between children receiving CIPN-associated
treatments versus those taking no CIPN-associated treatments and pain tolerance.
A post hoc power analysis conducted using the power Cox program in STATA 15
revealed that a sample size of 68 would provide 92% power to detect a large hazard ratio effect
with an α of 0.05.29 A post hoc power analysis suggested that 68 participants would provide 82%
power to detect a medium effect size correlation (r = 0.30) with an α of 0.05.30
Results
Emotion Regulation Group Differences
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When controlling for child age and sex, there were no emotion regulation group
differences in pain tolerance, Wald χ22= 1.38, P = 0.502. There were no emotion regulation
group differences in pain (first reported pain: F2,64 = 2.14, P = 0.126; worst reported pain: F2,64 =
2.14, P = 0.127; reported pain at pain tolerance: F2,64 = 1.67, P = 0.197) or upset (first reported
upset: F2,47 = 1.68, P = 0.194; worst reported upset: F2,64 = 1.39, P = 0.257; reported upset at
pain tolerance: F2,64 = 0.86, p = 0.429).
Pain Tolerance and Self-Report Pain and Upset
On average, children exhibited pain tolerance of 118.22 seconds (SD = 101.18; median =
67.00; interquartile range [IQR]: 26.25 to 240.00 s). A bimodal distribution was present with
60% of the participants removing their hand on or before the 105 second mark (ie, 1.75 min)
whereas the other 40% kept their hand in the water the entire 4-minute ceiling. On average,
children reported a pain severity of 5.07 (SD = 3.47; median = 5.00; IQR: 2.00 to 9.00) at their
first report of pain, a pain severity of 5.94 (SD = 3.54; median = 6.00; IQR: 3.00 to10.00) at their
max report of pain, and a pain severity of 5.33 (SD = 3.72; median = 5.00; IQR: 2.00 to 9.00) at
the time they reached pain tolerance (ie, removed their hand from the water). Children reported
an average upset rating of 3.09 (SD = 3.82; median = 1.00; IQR: 0.00 to 6.00) at their first report
of upset, an upset rating of 3.79 (SD = 3.95; median = 2.00; IQR: 0.00 to 8.00) at their max
report of upset, and 3.22 (SD = 3.85; median = 2.00; IQR: 0.00 to 6.00) at the time they reached
pain tolerance. Child pain and upset were positively correlated, r67 = 0.71, P < 0.001. Further,
greater pain tolerance was associated with lower pain at first reported pain (r65 = -0.48, P <
0.001), marginally associated with lower pain at worst reported pain (r65 = -0.23, P = 0.070), and
associated with lower pain at pain tolerance (r65 = -0.37, P = 0.002). Similarly, greater pain
tolerance was associated with lower upset at first reported upset (r65 = -0.45, P < 0.001), worst
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reported upset (r65 = -0.33, P = 0.007), and reported upset at pain tolerance (r65 = -0.41, P =
0.001).
Factors Associated with Child Pain Tolerance and Self-Reported Pain and Upset
Children who were older were more likely to demonstrate higher pain tolerance, r68 =
0.27, P = 0.027. Children who were older also tended to report less pain severity (first reported
pain: r67 = -0.26, P = 0.032; worst reported pain [marginal]: r67 = -0.22, P = 0.075; reported pain
at pain tolerance [marginal]: r67 = -0.24, P = 0.051) and upset (first reported upset [marginal]: r67
= -0.23, P = 0.061; worst reported upset: r67 = -0.28, P = 0.022; reported upset at pain tolerance
[non-significant]: r67 = -0.18, P = 0.142). Sex was not associated with pain tolerance or selfreported pain and upset, P’s > 0.05. Higher anxiety sensitivity tended to be associated with
higher pain (first reported pain: r56 = 0.30, P = 0.024; worst reported pain: r56 = 0.33, P = 0.015;
reported pain at pain tolerance [marginal]: r56 = 0.262, P = 0.051) and higher average upset (first
reported upset [marginal]: r67 = -0.23, P = 0.061; worst reported upset: r67 = -0.28, P = 0.022;
reported upset at pain tolerance [nonsignificant]: r67 = -0.18, P = 0.142). However, there was no
relationship between child anxiety sensitivity and pain tolerance, r57 = -0.16, p = 0.236.
Treatment Type
Some children (N = 56) were receiving chemotherapy agents known to cause CIPN (eg,
vincristine, cisplatin, and bortezomib) while others (N = 10) were not (2 children could not be
placed into one of the 2 groups and were therefore excluded from analyses using this variable). 31
There were no significant differences in age, sex, or anxiety between the 2 groups (P’s > 0.05).
When controlling for child age and sex, children taking CIPN-associated treatments exhibited
higher pain tolerance (Fig. 1), β = 0.84, SE = 0.38, Wald X21 = 4.88, P = 0.027, HR = 2.33, 95%
Two children could not be placed into one of the two groups and were therefore excluded from analyses using this
variable.
1
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confidence interval (1.10-4.92). Specifically, the hazard rate of hand removal of a child who was
not taking an agent associated with CIPN was 2.33 times greater than of a child receiving such a
medication. Further, of the 56 children receiving CIPN-associated treatment, 46% kept their
hand in the water for the entire 4-minute period while only 10% of the children not taking such
agents kept their hand in the water for the entire time. Given that anxiety sensitivity and selfreported pain and upset were also associated with pain tolerance, these variables were controlled
for (along with child age and sex), in a second Cox hazard model. In this model, children taking
CIPN-associated treatments again exhibited higher pain tolerance, β = 1.05, SE = 0.48, Wald X21
= 4.81, P = 0.028, HR = 2.84, 95% confidence interval (1.12 - 7.23).
Discussion
This study observed the pain response of children undergoing treatment for cancer during
the CPT, a widely used experimental pain task in children. Under the conditions of this study, we
found children with cancer exhibited average pain tolerance of ~2 minutes and 40% of
participants kept their hands in the cold water for the entire 4-minute duration of the CPT.
Moreover, we determined that several demographic and treatment-related factors impacted pain
response, including age, anxiety sensitivity, and chemotherapy agents.
In terms of demographic variables, similar to previous findings in studies of healthy
children and clinical populations, 5,6,32,33 pain tolerance in our sample was higher in older
children compared to younger participants. Additionally, older children reported less severe pain
and upset throughout the CPT. Children who were more anxious reported marginally more pain
and upset but exhibited no difference in pain tolerance compared to less anxious children
suggesting that the interrelation between anxiety, pain, and upset did not influence the behavioral
outcome of pain tolerance. We did not observe differences in pain tolerance or pain and upset
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severity ratings between male and female participants. Given that findings on the relationship
between pain tolerance and sex have been mixed5,6,32,34-36 and that they may be age dependent,37
further research is needed on potential sex differences in pain in this population. Nevertheless,
understanding how demographic variables are associated with pain processing allows for an
understanding of how they may influence pain processing over time. For example, if young
children or those with greater anxiety sensitivity experience pain, their experience may be more
traumatic relative to a much older child or a child with less anxiety sensitivity. This traumatic
experience may have greater negative effects on their future perception and anticipation of pain.
In terms of pain response, it can be difficult to compare findings with extant literature due
to slight differences in CPT methodology, particularly with regard to water temperature, ceiling
length, and whether the ceiling was informed or uninformed. Nonetheless, placing our data on
pain tolerance in the context of existing research seems to suggest that our findings are at least
consistent with extant literature (e.g., Trapanotto et al5 and Birnie et al38) and may even indicate
that children undergoing cancer treatment demonstrate increased pain tolerance when compared
to healthy children. For example, Myers et al32 employed a sample with a similar age range and
water temperature to our sample and their results revealed tolerance at closer to 1 minute, rather
than the 2 minutes in the present study. In addition, a large number of children (40%) in the
current study kept their hands in the cold water for the entire 4-minute ceiling. However, Myers
and colleagues’ participants also endured multiple pain tasks throughout their experiment and
although the other pain task was counter balanced with the CPT, this may have influenced pain
tolerance. In addition, Myers and colleagues’ instructions to their participants were to keep their
hand in the water for “as long as they could” while ours may have alluded to children that they
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only had to keep their hand in for a few minutes making our instructions more similar to those of
an informed ceiling.
One explanation for the finding of the high pain tolerance in our sample could be the
impact of the cancer treatment children were receiving. In particular, the majority of children
were receiving chemotherapy agents known to cause peripheral neuropathy (CIPN). Indeed,
children receiving CIPN-associated treatments reported lower pain and upset severity and
demonstrated higher pain tolerance compared to children not receiving such treatments.
Therefore, it is at least possible that chemotherapy agents may impact children’s pain response in
a manner that decreases sensitivity to pain. The observation of diminished distress and pain
response may be explained by symptoms of sensory and/or autonomic nerve damage or
dysfunction, such as hypoalgesia or vasomotor abnormalities.19 As mentioned in the
introduction, CIPN is known to cause decreased reflexes and a loss of feeling or sensitivity to
temperature and tactile stimuli, which may decrease patients’ perception and response to various
external stimuli including pain (for review see Gilchrist20). However, although one may
hypothesize that decreased pain response could have some benefits, CIPN has negative
consequences in terms of sensation (eg, numbness, tingling, burning) that may interfere with
procedural pain response but make overall pain management during cancer treatment more
complicated. For example, children who have decreased pain sensitivity may be less likely to
notice injuries. Interestingly, there were no significant differences in age, sex, or anxiety between
children receiving CIPN-associated treatments and those who were not, making it unlikely that
these could have explained the group differences in pain tolerance.
In interpreting our data, it is important to be mindful of the fact that our sample size was
small and heterogeneous, consisting of children diagnosed with a variety of cancer types and
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undergoing an array of treatment protocols, and therefore may have limited generalizability. This
was especially true in our analyses comparing children taking CIPN-associated treatments (N =
56) and those who were not (N = 10); thus, it is possible results may not replicate in a larger
sample size. A second limitation was our categorization of CIPN. Although it was surmised that
children receiving CIPN-associated treatments could be experiencing neuropathy, the actual
presence and characteristics of neuropathy were not assessed nor was the length of time they had
been receiving treatment. As new measures of treatment-induced neuropathies are created and
validated, a more detailed understanding of the relationship between CIPN and pain behavior
may be observed.39 It will be important to explore how stage and length of treatment may
influence pain response. Although data on this were not collected, children were likely at
difference phases of treatment and therefore frequency and dosing of chemotherapy varied.
Furthermore, no healthy comparison group was used in this study. A healthy comparison group
would provide a clearer assessment of the differences in pain response to the CPT between
children taking chemotherapy agents known to cause CIPN, children with cancer who were not
taking such agents, and children without cancer.
An additional limitation of the study was the perceived control as a result of the
experimental demands. Children who undergo repeated medical procedures are not provided
with the ability to discontinue a painful procedure. Therefore the capacity to end the
experimental pain task at their own discretion may have afforded a shift in participant focus,
perceived power or predictability during the CPT, consistent with extant literature documenting
differences in pain tolerance based upon knowledge of the time-limited nature of the task.12
Therefore, knowing that they could withdraw their hand at any time may have influenced their
pain perception. Finally, a criticism of the CPT is that it may not relate to real world pain
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experience and this may be particularly relevant in the pediatric oncology population. Pain
sensation is comprised of more than simply nociceptive input. There are affective as well as
sensory components to the experience of pain.40 In children with cancer, these affective
components may be particularly salient; a child with cancer who experiences pain may worry
that it signals a worsening of the cancer or a procedure may lead to procedural anxiety that may
not manifest during an experimental pain task. Thus, it will be important to examine how pain
responses to the CPT may predict responses to real world pain for children with cancer.
Children with cancer routinely undergo painful procedures. Therefore, the findings in this
study may be useful for future research aiming to mitigate the pain experienced during these
procedures and prevent chronic pain in survivorship, given the growing evidence of higher rates
of chronic pain in childhood cancer survivors.41 Our results suggest that cancer treatment may
impact children’s pain response. Although more data is needed to confirm this finding, future
research would be helpful in identifying how this impacts response to pain during treatment.
Future investigations of pain response in this population may also benefit from standardized
measures to assess CIPN symptom severity and additional physiological data to further assess
the potential impact of chemotherapy agents on children’s response to pain. Alternative methods
of experimental pain induction may also be considered in evaluating pain behaviors in this
population, as well as the use of informed time limits of pain induction. As we learn more about
the pain experiences of children with cancer, this body of knowledge can be used to inform pain
management approaches in this vulnerable population.
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Figure 1. Hazard function demonstrating pain tolerance of children taking or not taking agents
associated with chemotherapy-induced peripheral neuropathy (CIPN).

